Increasing prevalence of cardiovascular diseases and advancements in oncology therapies are driving growth in the global enzyme inhibitor market. Rising adoption of RNA-based inhibitors and small ...

DKSH has been appointed by MSD (Thailand) Ltd. to support its expansion efforts in Thailand. This collaboration aims to ...

Merck has become inexpensive again and combines a good growth outlook with a nice and growing dividend. Learn why MRK stock ...

To celebrate the online launch collaboration, JD Health and Merck hosted a special release event for the new medication at ...

Pharmaceutical Suspension Global market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033. The Business Research Company's Early Year-End Sa ...

When managing complex chronic dermatologic diseases, efforts to incorporate alternative treatments can add efficacy, patient ...

Evaluate the competition with an in-depth report: What Key Players Are Driving the Pharmaceutical Water Market? The pharmaceutical water market's growth is spurred on by key players including Merck & ...

APSA-02 is a biologic commercialized by Armata Pharmaceuticals, with a leading Phase II program in Bacteremia.

Amid an outpouring of frustration with for-profit health insurance sparked by the assassination of UnitedHealthcare CEO Brian ...

Wall Street analysts who follow Viking and Summit expect further gains in 2025. Quick gains are often lost on Wall Street, ...